REGN vs TTEC · P/E 14, rev $14.34B vs rev $2.21B
Regeneron Pharmaceuticals Inc (REGN) versus TTEC Holdings Inc (TTEC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
TTEC Holdings Inc (TTEC) is a information technology services company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TTEC revenue for 2024-12-31 was $2.21B. Net income was -$310.6M. Revenue was down 10.4% from 2023-12-31 to 2024-12-31. TTEC currently screens at market cap $247.3M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TTEC currently screens at market cap $247.3M.
Not investment advice. Open the REGN and TTEC stock pages for the full models.
Not investment advice.